다사티닙
|
|
다사티닙 속성
- 녹는점
- 275-286°C
- 밀도
- 1.408±0.06 g/cm3(Predicted)
- 저장 조건
- Sealed in dry,Store in freezer, under -20°C
- 용해도
- DMSO에 용해됩니다(최대 200mg/ml).
- 산도 계수 (pKa)
- 10.94±0.70(Predicted)
- 물리적 상태
- 백색 분말.
- 색상
- 흰색 또는 황백색
- 안정성
- 제공된 대로 구매일로부터 1년 동안 안정적입니다. DMSO의 솔루션은 -20°에서 최대 2개월 동안 보관할 수 있습니다.
- InChIKey
- ZBNZXTGUTAYRHI-UHFFFAOYSA-N
- SMILES
- S1C(C(NC2=C(C)C=CC=C2Cl)=O)=CN=C1NC1C=C(N2CCN(CCO)CC2)N=C(C)N=1
- CAS 데이터베이스
- 302962-49-8(CAS DataBase Reference)
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
HS 번호 | 29341000 |
---|
다사티닙 C화학적 특성, 용도, 생산
개요
Dasatinib, developed and marketed by Bristol Myers, is the first approved oral tyrosine kinase inhibitor which binds to multiple conformations of ABL kinase for the treatment of two leukemia indications: chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Dasatinib is a highly potent, ATPcompetitive ATPcompetitive kinase inhibitor which, at nanomolar concentrations, inhibits BCR-ABL, SRC family, c-KIT, EPHA2 and PDGFR-B.화학적 성질
Pale-Yellow SolidClass: non-receptor tyrosine kinase
Treatment: CML, ALL
Oral bioavailability = 14–34%
Elimination half-life = 3–5 h
Protein binding = 96%
일반 설명
Dasatinib is available in 20-, 50-, and 70-mg tablets fororal administration in the treatment of CML and ALL thatare Ph1 positive. Although dasatinib is more potent thanimatinib, bioavailability is much lower with values rangingbetween 14% to 34%. The agent is extensively metabolizedwith as many as 29 metabolites seen as result of oxidationby primarily CYP3A4 and phase II conjugation.The agent may act as an inhibitor of CYP3A4 andCYP2C8. Metabolism does give an active metabolite, but this accounts for only 5% of the total and is not believed tobe important for the overall activity of the agent. Dasatinibis 95% protein bound with a terminal half-life of 3 to5 hours. The majority of the drug and metabolites are eliminatedin the feces. The most common side effects are skinrash, nausea, diarrhea, and fatigue. Serious side effects includemyelosuppression appearing as neutropenia andthrombocytopenia, bleeding of the brain and GI tract, andfluid retention.다사티닙 준비 용품 및 원자재
원자재
2-(4-(6-((5-((2-chloro-6-Methylphenyl)carbaMoyl)thiazol-2-yl)aMino)-2-MethylpyriMidin-4-yl)piperazin-1-yl)ethyl acetate
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide
2-아미노-N-(2-클로로-6-메틸페닐)티아졸-5-카르복스아미드
1-(2-하이드록시에틸)피페라진
준비 용품
다사티닙 공급 업체
글로벌( 540)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
AFINE CHEMICALS LIMITED | +86-0571-85134551 |
info@afinechem.com | China | 15395 | 58 |
Yangzhou Qinyuan Pharmatech Co.,ltd | +86-18752526868 |
jennysun@yzqyyykj.com | China | 71 | 58 |
Hefei TianRui Pharmaceutical Chemical Co., Ltd. | +86-0551-68665055 +86-+86-18616906106 |
sales@trywchem.com | China | 129 | 58 |
SHANDONG BOYUAN PHARMACEUTICAL CO., LTD. | +86-0531-69954981 +8615666777973 |
dwyane.wang@boyuanpharm.com | China | 211 | 58 |
Hebei Guanlang Biotechnology Co,.LTD | +8619930503252 |
daisy@crovellbio.com | China | 5828 | 58 |
Henan Bao Enluo International TradeCo.,LTD | +86-17331933971 +86-17331933971 |
deasea125996@gmail.com | China | 2503 | 58 |
Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +8617865335152 |
Mandy@hangyubiotech.com | China | 10977 | 58 |
Shaanxi TNJONE Pharmaceutical Co., Ltd | +8618740459177 |
sarah@tnjone.com | China | 1143 | 58 |
Capot Chemical Co.,Ltd. | 571-85586718 +8613336195806 |
sales@capotchem.com | China | 29798 | 60 |
Beijing Cooperate Pharmaceutical Co.,Ltd | 010-60279497 |
sales01@cooperate-pharm.com | CHINA | 1811 | 55 |
다사티닙 관련 검색:
1-아미노에틸피페라진 에피클로로하이드린 NIZA티딘 클로로아세트산 클로로디플루오르메탄
2-(METHYLSULFONYL)ETHANOL
Gefitinib
Lapatinib
Sunitinib
Imatinib
2-Ethylhexyl ferulate
2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide
dasatinib monohydrate,Dasatinib(TINIBS)
Dacomitinib (PF299804)
4-AMINO-6-(4-METHYL-1-PIPERAZINYL)PYRIMIDINE
Dasatinib Metabolite M4-d8,N-Deshydroxyethyl Dasatinib-d8
Dasatinib Carboxylic Acid
Dasatinib-d8 N-Oxide